Metabolism and metabolic burden by α1-antitrypsin production in human AGE1.HN cells

Metabolic Engineering

Volumn 16, Issue 1, 2013, Pages 103-114

  Niklas, Jens ^a   Priesnitz, Christian ^a   Rose, Thomas ^b   Sandig, Volker ^b   Heinzle, Elmar ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b PROBIOGEN AG   (Germany)

Author keywords

AAT deficiency; Biopharmaceutical; Cell culture; Mammalian cell; Metabolic flux; Therapeutic protein

Indexed keywords

AAT DEFICIENCY; BIOPHARMACEUTICAL; MAMMALIAN CELLS; METABOLIC FLUX; THERAPEUTIC PROTEIN;

AMINO ACIDS; CELL CULTURE; MACHINERY; PHYSIOLOGY; RNA;

METABOLISM;

ALPHA 1 ANTITRYPSIN; GLUTAMIC ACID; GLYCINE; LIPID; PHOSPHATIDYLCHOLINE; RNA;

AGE1.HN CELL; ARTICLE; BRAIN CELL; ENERGY METABOLISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ALPHA 1-ANTITRYPSIN; CELL LINE, TRANSFORMED; ENERGY METABOLISM; HUMANS; MODELS, BIOLOGICAL; RECOMBINANT PROTEINS;

EID: 84874560748     PISSN: 10967176     EISSN: 10967184     Source Type: Journal    
DOI: 10.1016/j.ymben.2013.01.002     Document Type: Article

References (53)

1. A1AT-Group Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin deficiency registry study group. Am. J. Respir. Crit. Care Med. 1998, 158:49-59.
2. Akopian D., Medh J.D. Simultaneous isolation of total cellular lipids and RNA from cultured cells. Biotechniques 2006, 41(426):428-430.
3. Alete D.E., Racher A.J., Birch J.R., Stansfield S.H., James D.C., Smales C.M. Proteomic analysis of enriched microsomal fractions from GS-NS0 murine myeloma cells with varying secreted recombinant monoclonal antibody productivities. Proteomics 2005, 5:4689-4704.
4. Anthony J.R., Anthony L.C., Nowroozi F., Kwon G., Newman J.D., Keasling J.D. Optimization of the mevalonate-based isoprenoid biosynthetic pathway in Escherichia coli for production of the anti-malarial drug precursor amorpha-4,11-diene. Metab. Eng. 2009, 11:13-19.
5. Baik J.Y., Gasimli L., Yang B., Datta P., Zhang F., Glass C.A., Esko J.D., Linhardt R.J., Sharfstein S.T. Metabolic engineering of Chinese hamster ovary cells: towards a bioengineered heparin. Metab. Eng. 2012, 14:81-90.
6. Barnes L.M., Moy N., Dickson A.J. Phenotypic variation during cloning procedures: analysis of the growth behavior of clonal cell lines. Biotechnol. Bioeng. 2006, 94:530-537.
7. Blanchard V., Liu X., Eigel S., Kaup M., Rieck S., Janciauskiene S., Sandig V., Marx U., Walden P., Tauber R., Berger M. N-glycosylation and biological activity of recombinant human alpha1-antitrypsin expressed in a novel human neuronal cell line. Biotechnol. Bioeng. 2011, 108:2118-2128.
8. Bonarius H.P., Hatzimanikatis V., Meesters K.P., de Gooijer C.D., Schmid G., Tramper J. Metabolic flux analysis of hybridoma cells in different culture media using mass balances. Biotechnol. Bioeng. 1996, 50:299-318.
9. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
10. Carpino L., Han G. 9-fluorenylmethoxycarbonyl amino-protecting group. J. Org. Chem. 1972, 37:3404-3409.
11. Chusainow J., Yang Y.S., Yeo J.H., Toh P.C., Asvadi P., Wong N.S., Yap M.G. A study of monoclonal antibody-producing CHO cell lines: what makes a stable high producer?. Biotechnol. Bioeng. 2009, 102:1182-1196.
12. Deshpande R., Yang T.H., Heinzle E. Towards a metabolic and isotopic steady state in CHO batch cultures for reliable isotope-based metabolic profiling. Biotechnol. J. 2009, 4:247-263.
13. Dietmair S., Nielsen L.K., Timmins N.E. Mammalian cells as biopharmaceutical production hosts in the age of omics. Biotechnol. J. 2011, 7:75-89.
14. Dinnis D.M., James D.C. Engineering mammalian cell factories for improved recombinant monoclonal antibody production: lessons from nature?. Biotechnol. Bioeng. 2005, 91:180-189.
15. Gildea T.R., Shermock K.M., Singer M.E., Stoller J.K. Cost-effectiveness analysis of augmentation therapy for severe alpha1-antitrypsin deficiency. Am. J. Respir. Crit. Care Med. 2003, 167:1387-1392.
16. Grand R.J., Gallimore P.H. Modulation of the level of expression of cellular genes in adenovirus 12-infected and transformed human cells. Embo J. 1986, 5:1253-1260.
17. Hayduk E.J., Lee K.H. Cytochalasin D can improve heterologous protein productivity in adherent Chinese hamster ovary cells. Biotechnol. Bioeng. 2005, 90:354-364.
18. Hung F., Deng L., Ravnikar P., Condon R., Li B., Do L., Saha D., Tsao Y.S., Merchant A., Liu Z., Shi S. mRNA stability and antibody production in CHO cells: improvement through gene optimization. Biotechnol. J. 2011, 5:393-401.
19. Jenkins N., Castro P., Menon S., Ison A., Bull A. Effect of lipid supplements on the production and glycosylation of recombinant interferon-gamma expressed in CHO cells. Cytotechnology 1994, 15:209-215.
20. Jordan I., Vos A., Beilfuss S., Neubert A., Breul S., Sandig V. An avian cell line designed for production of highly attenuated viruses. Vaccine 2009, 27:748-756.
21. Karnaukhova E., Ophir Y., Golding B. Recombinant human alpha-1 proteinase inhibitor: towards therapeutic use. Amino Acids 2006, 30:317-332.
22. Kelly E., Greene C.M., Carroll T.P., McElvaney N.G., O'Neill S.J. Alpha-1 antitrypsin deficiency. Respir. Med. 2010, 104:763-772.
23. Khoo S.H., Falciani F., Al-Rubeai M. A genome-wide transcriptional analysis of producer and non-producer NS0 myeloma cell lines. Biotechnol. Appl. Biochem. 2007, 47:85-95.
24. Kolarich D., Weber A., Turecek P.L., Schwarz H.P., Altmann F. Comprehensive glyco-proteomic analysis of human alpha1-antitrypsin and its charge isoforms. Proteomics 2006, 6:3369-3380.
25. Kromer J.O., Fritz M., Heinzle E., Wittmann C. In vivo quantification of intracellular amino acids and intermediates of the methionine pathway in Corynebacterium glutamicum. Anal. Biochem. 2005, 340:171-173.
26. Kuystermans D., Krampe B., Swiderek H., Al-Rubeai M. Using cell engineering and omic tools for the improvement of cell culture processes. Cytotechnology 2007, 53:3-22.
27. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
28. Lee Y.Y., Wong K.T., Nissom P.M., Wong D.C., Yap M.G. Transcriptional profiling of batch and fed-batch protein-free 293-HEK cultures. Metab. Eng. 2007, 9:52-67.
29. Long G.L., Chandra T., Woo S.L., Davie E.W., Kurachi K. Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant. Biochemistry 1984, 23:4828-4837.
30. Ma S.M., Garcia D.E., Redding-Johanson A.M., Friedland G.D., Chan R., Batth T.S., Haliburton J.R., Chivian D., Keasling J.D., Petzold C.J., Lee T.S., Chhabra S.R. Optimization of a heterologous mevalonate pathway through the use of variant HMG-CoA reductases. Metab. Eng. 2011, 13:588-597.
31. Ng S.K., Wang D.I., Yap M.G. Application of destabilizing sequences on selection marker for improved recombinant protein productivity in CHO-DG44. Metab. Eng. 2007, 9:304-316.
32. Nguyen B., Jarnagin K., Williams S., Chan H., Barnett J. Fed-batch culture of insect cells: a method to increase the yield of recombinant human nerve growth factor (rhNGF) in the baculovirus expression system. J. Biotechnol. 1993, 31:205-217.
33. Niklas J., Heinzle E. Metabolic flux analysis in systems biology of mammalian cells. Adv. Biochem. Eng. Biotechnol. 2011, 10.1007/10_2011_99.
34. Niklas J., Hollemeyer K., Heinzle E. High-throughput phospholipid quantitation in mammalian cells using matrix-assisted laser desorption ionization-time of flight mass spectrometry with N-trifluoroacetyl-phosphatidylethanolamine as internal standard. Anal. Biochem. 2011, 419:351-353.
35. Niklas J., Nonnenmacher Y., Rose T., Sandig V., Heinzle E. Quercetin treatment changes fluxes in the primary metabolism and increases culture longevity and recombinant alpha(1)-antitrypsin production in human AGE1.HN cells. Appl. Microbiol. Biotechnol. 2011.
36. Niklas J., Noor F., Heinzle E. Effects of drugs in subtoxic concentrations on the metabolic fluxes in human hepatoma cell line Hep G2. Toxicol. Appl. Pharmacol. 2009, 240:327-336.
37. Niklas J., Priesnitz C., Rose T., Sandig V., Heinzle E. Primary metabolism in the new human cell line AGE1.HN at various substrate levels: increased metabolic efficiency and alpha(1)-antitrypsin production at reduced pyruvate load. Appl. Microbiol. Biotechnol. 2011, 93:1637-1650.
38. Niklas J., Sandig V., Heinzle E. Metabolite channeling and compartmentation in the human cell line AGE1.HN determined by 13C labeling experiments and 13C metabolic flux analysis. J. Biosci. Bioeng. 2011, 10.1016/j.jbiosc.2011.07.021.
39. Niklas J., Schrader E., Sandig V., Noll T., Heinzle E. Quantitative characterization of metabolism and metabolic shifts during growth of the new human cell line AGE1.HN using time resolved metabolic flux analysis. Bioprocess Biosyst. Eng. 2011, 34:533-545.
40. Petrache I., Hajjar J., Campos M. Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency. Biologics 2009, 3:193-204.
41. Roth M. Fluorescence reaction for amino acids. Anal. Chem. 1971, 43:880-882.
42. Seamans T.C., Gould S.L., DiStefano D.J., Silberklang M., Robinson D.K. Use of lipid emulsions as nutritional supplements in mammalian cell culture. Ann. N Y Acad. Sci. 1994, 745:240-243.
43. Seth G., Hossler P., Yee J.C., Hu W.S. Engineering cells for cell culture bioprocessing-physiological fundamentals. Adv. Biochem. Eng. Biotechnol. 2006, 101:119-164.
44. Seth G., Philp R.J., Lau A., Jiun K.Y., Yap M., Hu W.S. Molecular portrait of high productivity in recombinant NS0 cells. Biotechnol. Bioeng. 2007, 97:933-951.
45. Shaffer A.L., Shapiro-Shelef M., Iwakoshi N.N., Lee A.H., Qian S.B., Zhao H., Yu X., Yang L., Tan B.K., Rosenwald A., Hurt E.M., Petroulakis E., Sonenberg N., Yewdell J.W., Calame K., Glimcher L.H., Staudt L.M. XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity 2004, 21:81-93.
46. Smales C.M., Dinnis D.M., Stansfield S.H., Alete D., Sage E.A., Birch J.R., Racher A.J., Marshall C.T., James D.C. Comparative proteomic analysis of GS-NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rate. Biotechnol. Bioeng. 2004, 88:474-488.
47. Sriburi R., Jackowski S., Mori K., Brewer J.W. XBP1: a link between the unfolded protein response, lipid biosynthesis, and biogenesis of the endoplasmic reticulum. J. Cell Biol. 2004, 167:35-41.
48. Stephanopoulos G.N., Aristidou A.A., Nielsen J. Metabolic Engineering: Principles and Methodologies 1998, Academic Press, San Diego, California, USA.
49. Tigges M., Fussenegger M. Xbp1-based engineering of secretory capacity enhances the productivity of Chinese hamster ovary cells. Metab. Eng. 2006, 8:264-272.
50. Tsao C.Y., Hooshangi S., Wu H.C., Valdes J.J., Bentley W.E. Autonomous induction of recombinant proteins by minimally rewiring native quorum sensing regulon of E. coli. Metab. Eng. 2010, 12:291-297.
51. Voedisch B., Patoux A., Sterkenburgh J., Buchs M., Barry E., Allard C., Geisse S. About making a CHO production cell line "research-friendly" by genetic engineering. BMC Proc. 2011, 5(Suppl 8):P132.
52. White E., Spector D., Welch W. Differential distribution of the adenovirus E1A proteins and colocalization of E1A with the 70-kilodalton cellular heat shock protein in infected cells. J. Virol. 1988, 62:4153-4166.
53. Yee J.C., Gerdtzen Z.P., Hu W.S. Comparative transcriptome analysis to unveil genes affecting recombinant protein productivity in mammalian cells. Biotechnol. Bioeng. 2009, 102:246-263.